Cite
Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.
MLA
“Failure of a Repeat Course of Cyclooxygenase Inhibitor to Close a PDA Is a Risk Factor for Developing Chronic Lung Disease in ELBW Infants.” BMC Pediatrics, vol. 12, no. 1, Jan. 2012, pp. 10–16. EBSCOhost, https://doi.org/10.1186/1471-2431-12-10.
APA
Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants. (2012). BMC Pediatrics, 12(1), 10–16. https://doi.org/10.1186/1471-2431-12-10
Chicago
“Failure of a Repeat Course of Cyclooxygenase Inhibitor to Close a PDA Is a Risk Factor for Developing Chronic Lung Disease in ELBW Infants.” 2012. BMC Pediatrics 12 (1): 10–16. doi:10.1186/1471-2431-12-10.